Global Pharmaceuticals & Biotech Leverage Leaders

Stevanato Group

Market Cap: US$4.4b

Engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific.

ADMA Biologics

Market Cap: US$4.0b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

D&D Pharmatech

Market Cap: ₩4.1t

Engages in the research and development and manufacturing of pharmaceuticals in South Korea.

Sun Pharmaceutical Industries

Market Cap: ₹3.8t

A generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations, and active pharmaceutical ingredients (APIs) in India, the United States, and internationally.

Kalbe Farma

Market Cap: Rp51.9t

Develops, manufactures, and trades in pharmaceutical products in Indonesia.

Zhejiang Medicine

Market Cap: CN¥14.2b

Manufactures and sells life nutrition and medical products in China and internationally.

Sunshine Guojian Pharmaceutical (Shanghai)

Market Cap: CN¥37.2b

A biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs.

Aurobindo Pharma

Market Cap: ₹701.4b

A biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables.

Imeik Technology DevelopmentLtd

Market Cap: CN¥42.1b

Engages in the research and development, production, and transformation of biomedical soft tissue repair materials in China.

Asymchem Laboratories (Tianjin)

Market Cap: CN¥34.9b

Asymchem Laboratories (Tianjin) Co., Ltd.

Otsuka Holdings

Market Cap: JP¥4.9t

Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.

Tasly Pharmaceutical Group

Market Cap: CN¥22.6b

Researches, develops, manufactures, and sells medicines and related pharmaceuticals in China and internationally.

Financière de Tubize

Market Cap: €9.5b

Operates as a mono holding company whose sole investment is a stake in UCB which is a biopharma company in Belgium.

Biogen

Market Cap: US$26.4b

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.

SCHOTT Pharma KGaA

Market Cap: €2.2b

Develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide.

Jiangsu Hengrui PharmaceuticalsLtd

Market Cap: CN¥385.9b

A pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally.

Corcept Therapeutics

Market Cap: US$4.2b

Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

Alkem Laboratories

Market Cap: ₹678.8b

A pharmaceutical company, engages in the research and development, manufacture, and sale of pharmaceutical and nutraceutical products in India, the United States, and internationally.

Exelixis

Market Cap: US$11.1b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

Dianthus Therapeutics

Market Cap: US$2.3b

A clinical-stage biotechnology company, develops complement therapeutics for patients with severe autoimmune and inflammatory diseases.

Vaxcyte

Market Cap: US$7.0b

A clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.

ACADIA Pharmaceuticals

Market Cap: US$4.3b

A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.

United Therapeutics

Market Cap: US$20.2b

A biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.

Sino Biopharmaceutical

Market Cap: HK$118.7b

An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.

3SBio

Market Cap: HK$58.2b

An investment holding company, develops, produces markets, and sells biopharmaceutical products in Mainland China and internationally.

AstraZeneca Pharma India

Market Cap: ₹213.4b

A biopharmaceutical company, manufactures, markets, and trades in pharmaceutical products in India and internationally.

Hanmi Pharm

Market Cap: ₩6.1t

A biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally.

Peptron

Market Cap: ₩7.1t

Engages in the development of peptide-based medicines.

Chugai Pharmaceutical

Market Cap: JP¥14.5t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

Abbott India

Market Cap: ₹588.1b

Operates as a pharmaceutical company in India.

Jiangsu Nhwa Pharmaceutical

Market Cap: CN¥24.0b

Engages in production, marketing, and services related to central nervous system drugs in China.

Zhejiang Jiuzhou Pharmaceutical

Market Cap: CN¥16.1b

Operates as contract development and manufacturing organization (CDMO) company in China and internationally.

Structure Therapeutics

Market Cap: US$6.1b

A clinical stage global biopharmaceutical company, develops and delivers novel oral small molecule therapeutics to treat various chronic diseases with unmet medical needs in the United States.

Regeneron Pharmaceuticals

Market Cap: US$76.1b

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.

Sanofi

Market Cap: €95.7b

Engages in the research, development, manufacture, and marketing of therapeutic solutions.

Camurus

Market Cap: SEK 39.8b

A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.